Erythropoietin Resistance Index helps predict mortality in CKD patients
A recent study published in the Renal Failure found the intricate relationship between anemia, chronic kidney disease (CKD) and mortality risks in patients undergoing maintenance hemodialysis (MHD). The study was conducted using data from the China Dialysis Outcomes and Practice Patterns Study (DOPPS) 5. This focused on investigating the factors influencing the erythropoietin resistance index (ERI) and its correlation with survival outcomes.
This study encompassed a total of 1270 MHD subjects with an average age of 60 and discovered a critical link between ERI and mortality. ERI which is calculated as ESA (erythropoiesis-stimulating agents) dosage per week divided by weight post-dialysis and hemoglobin levels emerged as a potential predictor of all-cause mortality. The subjects were divided into two groups based on the median ERI of 14.03.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.